Kathleen I Pritchard Selected Research

Kathleen I Pritchard Research Topics

Disease

157	Breast Neoplasms (Breast Cancer) 12/2021 - 01/2002
59	Neoplasms (Cancer) 01/2022 - 01/2002
12	Neoplasm Metastasis (Metastasis) 01/2018 - 12/2003
8	Osteoporosis 12/2021 - 11/2003
8	Obesity 01/2020 - 01/2002
4	Pain (Aches) 07/2016 - 10/2006
4	Exanthema (Rash) 01/2016 - 01/2013
3	Metabolic Bone Diseases (Osteopenia) 07/2017 - 11/2008
3	Anemia 07/2017 - 03/2007
3	Arthralgia (Joint Pain) 04/2017 - 11/2003
3	Bone Fractures (Bone Fracture) 07/2016 - 09/2005
3	Fatigue 03/2016 - 02/2012
3	Triple Negative Breast Neoplasms 10/2014 - 08/2007
3	Disease Progression 05/2013 - 11/2011
3	Nausea 12/2010 - 12/2006
3	Hot Flashes 12/2010 - 11/2003
3	Vomiting 02/2010 - 12/2006
3	Insulin Resistance 04/2009 - 11/2005
2	Second Primary Neoplasms (Neoplasms, Second) 07/2018 - 05/2017
2	Myalgia 04/2017 - 11/2003
2	Hypertension (High Blood Pressure) 04/2017 - 01/2010
2	Dyspnea (Shortness of Breath) 04/2017 - 02/2012
2	Pathologic Complete Response 04/2016 - 01/2010
2	Neoplasm Micrometastasis 04/2016 - 07/2006
2	Diarrhea 05/2015 - 12/2008
2	Lymphedema (Milroy Disease) 10/2013 - 07/2008
2	Uterine Hemorrhage (Uterine Bleeding) 04/2013 - 11/2003
2	Stomatitis 02/2012 - 12/2009
2	Bone Resorption 09/2011 - 08/2006
2	Type 2 Diabetes Mellitus (MODY) 02/2011 - 12/2008
2	Constipation 12/2010 - 12/2008
2	Neutropenia 01/2010 - 12/2009
2	Amenorrhea 09/2005 - 01/2005
1	Phototoxic Dermatitis (Phototoxicity) 01/2022
1	DNA Repair-Deficiency Disorders (Chromosome Instability Syndromes) 01/2022
1	Osteoporotic Fractures 12/2021
1	Cognitive Dysfunction 10/2020
1	Dementia (Dementias) 01/2020

Drug/Important Bio-Agent (IBA)

43	Hormones (Hormone)IBA 11/2019 - 08/2002
33	Tamoxifen FDA LinkGeneric 12/2021 - 08/2002
30	Aromatase InhibitorsIBA 12/2021 - 08/2002
17	exemestane (Aromasin)FDA Link 01/2018 - 10/2005
16	Estrogen ReceptorsIBA 11/2019 - 07/2002
15	Trastuzumab (Herceptin)FDA Link 01/2021 - 10/2008
14	AnthracyclinesIBA 12/2021 - 08/2005
14	Letrozole (Femara)FDA LinkGeneric 01/2018 - 11/2003
12	Cyclophosphamide (Cytoxan)FDA LinkGeneric 05/2015 - 12/2003
11	ErbB Receptors (EGF Receptor)IBA 01/2019 - 05/2006
11	Anastrozole (Arimidex)FDA LinkGeneric 01/2018 - 08/2002
11	Progesterone Receptors (Progesterone Receptor)IBA 11/2017 - 12/2003
10	Insulin (Novolin)FDA Link 01/2020 - 01/2002
10	Fluorouracil (Carac)FDA LinkGeneric 05/2015 - 12/2003
9	Methotrexate (Mexate)FDA LinkGeneric 05/2015 - 12/2003
8	Lapatinib (GW572016)FDA Link 01/2021 - 01/2013
8	Everolimus FDA Link 02/2016 - 02/2012
7	Biomarkers (Surrogate Marker)IBA 12/2021 - 08/2009
7	Estrogens (Estrogen)FDA Link 12/2021 - 04/2002
7	Epirubicin (Ellence)FDA LinkGeneric 01/2015 - 08/2005
6	human ERBB2 proteinIBA 07/2018 - 03/2011
6	Octreotide (Sandostatin)FDA LinkGeneric 01/2016 - 09/2011
5	ParaffinIBA 12/2021 - 05/2006
5	Pharmaceutical PreparationsIBA 01/2018 - 09/2008
5	Metformin (Glucophage)FDA LinkGeneric 07/2017 - 12/2008
5	Diphosphonates (Bisphosphonates)IBA 07/2017 - 12/2003
5	Bevacizumab (Avastin)FDA Link 10/2014 - 11/2011
4	Formaldehyde (Formol)FDA Link 12/2021 - 05/2006
4	LeptinIBA 01/2020 - 09/2005
4	Fulvestrant (Faslodex)FDA Link 11/2019 - 01/2003
4	taxaneIBA 05/2015 - 05/2008
4	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2010 - 12/2006
3	Vitamin D FDA LinkGeneric 01/2020 - 08/2009
3	DNA (Deoxyribonucleic Acid)IBA 12/2016 - 01/2005
3	Biological ProductsIBA 10/2016 - 07/2006
3	RNA (Ribonucleic Acid)IBA 01/2016 - 01/2010
3	Docetaxel (Taxotere)FDA Link 01/2015 - 01/2010
3	Aromatase (CYP19)IBA 07/2009 - 09/2005
3	LipidsIBA 04/2009 - 11/2005
2	MA 12 (MA12)IBA 12/2021 - 08/2012
2	Progesterone FDA LinkGeneric 12/2021 - 04/2002
2	Epidermal Growth Factor (EGF)IBA 04/2016 - 08/2013
2	RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA 11/2015 - 04/2012
2	Phenobarbital (Luminal)FDA Link 05/2015 - 01/2015
2	Glucose (Dextrose)FDA LinkGeneric 03/2015 - 04/2009
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 07/2014 - 02/2010
2	TOR Serine-Threonine KinasesIBA 08/2013 - 02/2012
2	Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA 02/2010 - 01/2010
2	Hematoxylin (Haematoxylon)IBA 01/2010 - 07/2006
2	Eosine Yellowish-(YS) (Eosin)IBA 01/2010 - 07/2006
2	tesmilifene (DPPE)IBA 01/2009 - 12/2006
2	CholesterolIBA 12/2008 - 11/2005
2	Gonadotropin-Releasing Hormone (GnRH)FDA Link 08/2007 - 01/2003
2	collagen type I trimeric cross-linked peptideIBA 10/2006 - 08/2006
2	Oncogene Proteins (Oncogene Protein)IBA 01/2006 - 01/2005
1	CX 5461IBA 01/2022
1	Inositol (Myoinositol)IBA 12/2021
1	NestinIBA 12/2021

Therapy/Procedure

85	Therapeutics 12/2021 - 08/2002
33	Drug Therapy (Chemotherapy) 12/2021 - 03/2003
22	Adjuvant Chemotherapy 10/2020 - 08/2005
4	Aftercare (After-Treatment) 11/2017 - 01/2005